Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-02-12 @ 9:58 AM
Study NCT ID:
NCT05312632
Status:
COMPLETED
Last Update Posted:
2024-09-23
First Post:
2022-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
Sponsor:
Eisai Korea Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-25
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-28
First Submit QC Date:
None
Study First Post Date:
2022-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-23
Results First Submit QC Date:
None
Results First Post Date:
2024-09-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-23
Last Update Post Date:
2024-09-23
Last Update Post Date Type:
ACTUAL